Abdelghani Achab

This inventor holds 24 USPTO granted patents and 2 published patent applications and 20 EPO patents, primarily in Pharmaceutical Inhibitors. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdelghani Achab. Retrieved from https://idiyas.com/inventor/abdelghani-achab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 20 (Patent Applications = 22)

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

22 out of 2,405

Merck Sharp + Dohme Corp.

patents

2 out of 70

Merck Sharp & Dohme LLC

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

HPK1 Inhibitors

IDO Inhibitors

PI3K Delta Inhibitors

Arginase Inhibitors

Fatty Acid Binding Protein

Purine Compounds

Spirotricycles

Tetrahydroquinoline

Biaryl Compounds

Cyclobutyl Compounds

Indazole Derivatives

Oxadiazole Compounds

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753190 - Spirotricycle RIPK1 inhibitors and methods of uses thereof (2026-10-06),

2. 12753163 - Diaminopyrimidine carboxamide inhibitors of HPK1 (2026-10-06),

3. 12275729 - Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2025-04-14),

4. 12240867 - Arginase inhibitors and methods of use (2025-03-04),

5. 12215116 - Arginase inhibitors and methods of use (2025-02-04),

6. 12180226 - Spirotricycle RIPK1 inhibitors and methods of uses thereof (2024-12-31),

7. 11498904 - Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2022-11-15),

8. 11319283 - Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2022-05-03),

9. 11274111 - Arginase inhibitors and methods of use (2022-03-15),

10. 11230547 - Purine inhibitors of human phosphatidylinositol 3-kinase delta (2022-01-25),

11. 11208407 - Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-12-28),

12. 11179389 - Purine inhibitors of human phosphatidylinositol 3-kinase delta (2021-11-23),

13. 11111232 - Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-09-07),

14. 11034661 - Substituted N'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors (2021-06-15),

15. 10995085 - Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2021-05-04),

Title: The Innovative Journey of Inventor Abdelghani Achab

Introduction: Abdelghani Achab, a talented inventor based in Melrose, MA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Abdelghani Achab holds several patents in various technological domains, showcasing his versatility and creativity in innovation. His latest patents focus on cutting-edge solutions in the fields of artificial intelligence and renewable energy.

Career Highlights: With a career spanning over two decades, Abdelghani Achab has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has not only revolutionized industries but has also improved the quality of life for many individuals.

Collaborations: Throughout his career, Abdelghani Achab has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful development of groundbreaking technologies.

Conclusion: In conclusion, Abdelghani Achab's passion for innovation, coupled with his dedication to pushing the boundaries of technology, has solidified his position as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.